Acadia Healthcare Co Inc has a consensus price target of $88.3 based on the ratings of 20 analysts. The high is $103 issued by SVB Leerink on August 26, 2022. The low is $69 issued by Credit Suisse on November 1, 2021. The 3 most-recent analyst ratings were released by Cantor Fitzgerald on July 10, 2024, July 9, 2024, and July 2, 2024, respectively. With an average price target of $90 between Cantor Fitzgerald, there's an implied 35.16% upside for Acadia Healthcare Co Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/10/2024 | Buy Now | 35.16% | Cantor Fitzgerald | Sarah James | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
07/09/2024 | Buy Now | 35.16% | Cantor Fitzgerald | Sarah James | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
07/02/2024 | Buy Now | 35.16% | Cantor Fitzgerald | Sarah James | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
05/22/2024 | Buy Now | 41.16% | RBC Capital | Ben Hendrix | → $94 | Reiterates | Outperform → Outperform | Get Alert |
05/17/2024 | Buy Now | 36.66% | TD Cowen | Gary Taylor | $101 → $91 | Maintains | Buy | Get Alert |
05/15/2024 | Buy Now | 33.65% | Barclays | Andrew Mok | $91 → $89 | Maintains | Overweight | Get Alert |
05/03/2024 | Buy Now | 5.12% | Mizuho | Ann Hynes | $84 → $70 | Maintains | Neutral | Get Alert |
05/02/2024 | Buy Now | 35.16% | B of A Securities | Kevin Fischbeck | $105 → $90 | Maintains | Buy | Get Alert |
05/02/2024 | Buy Now | 36.66% | Barclays | Andrew Mok | $100 → $91 | Maintains | Overweight | Get Alert |
04/25/2024 | Buy Now | 5.12% | Deutsche Bank | Pito Chickering | → $70 | Upgrade | Sell → Hold | Get Alert |
03/06/2024 | Buy Now | 26.15% | Mizuho | Ann Hynes | $77 → $84 | Maintains | Neutral | Get Alert |
03/06/2024 | Buy Now | 50.17% | Barclays | Andrew Mok | → $100 | Initiates | → Overweight | Get Alert |
03/05/2024 | Buy Now | 35.16% | Cantor Fitzgerald | Sarah James | → $90 | Reiterates | Neutral → Neutral | Get Alert |
03/04/2024 | Buy Now | 41.16% | RBC Capital | Ben Hendrix | → $94 | Reiterates | Outperform → Outperform | Get Alert |
03/01/2024 | Buy Now | 51.67% | TD Cowen | Gary Taylor | $86 → $101 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | 53.18% | UBS | Andrew Mok | $88 → $102 | Maintains | Buy | Get Alert |
01/05/2024 | Buy Now | 38.16% | Stephens & Co. | Scott Fidel | → $92 | Upgrade | Equal-Weight → Overweight | Get Alert |
11/07/2023 | Buy Now | 41.16% | RBC Capital | Ben Hendrix | $99 → $94 | Maintains | Outperform | Get Alert |
09/14/2023 | Buy Now | 27.65% | Cantor Fitzgerald | Joseph France | $83 → $85 | Maintains | Neutral | Get Alert |
07/31/2023 | Buy Now | 48.67% | RBC Capital | Ben Hendrix | $93 → $99 | Maintains | Outperform | Get Alert |
07/31/2023 | Buy Now | 42.66% | Credit Suisse | A.J. Rice | → $95 | Reiterates | Outperform → Outperform | Get Alert |
07/12/2023 | Buy Now | 24.64% | Stephens & Co. | Scott Fidel | → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
06/02/2023 | Buy Now | 24.64% | Stephens & Co. | Scott Fidel | → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
05/04/2023 | Buy Now | 42.66% | Credit Suisse | A.J. Rice | $93 → $95 | Maintains | Outperform | Get Alert |
04/28/2023 | Buy Now | 42.66% | Credit Suisse | Jonathan Yong | $93 → $95 | Maintains | Outperform | Get Alert |
04/27/2023 | Buy Now | 32.15% | Stephens & Co. | Scott Fidel | → $88 | Reiterates | → Equal-Weight | Get Alert |
04/24/2023 | Buy Now | 38.16% | UBS | Andrew Mok | $96 → $92 | Maintains | Buy | Get Alert |
04/20/2023 | Buy Now | -5.39% | Deutsche Bank | Pito Chickering | $75 → $63 | Downgrade | Hold → Sell | Get Alert |
03/06/2023 | Buy Now | 12.63% | Deutsche Bank | Pito Chickering | $82 → $75 | Maintains | Hold | Get Alert |
03/06/2023 | Buy Now | 20.14% | Mizuho | Ann Hynes | $87 → $80 | Maintains | Neutral | Get Alert |
03/01/2023 | Buy Now | 32.15% | Stephens & Co. | Scott Fidel | $92 → $88 | Maintains | Equal-Weight | Get Alert |
02/28/2023 | Buy Now | 38.16% | Stephens & Co. | Scott Fidel | → $92 | Reiterates | → Equal-Weight | Get Alert |
12/12/2022 | Buy Now | 39.66% | RBC Capital | Ben Hendrix | $94 → $93 | Maintains | Outperform | Get Alert |
12/12/2022 | Buy Now | 42.66% | Loop Capital | Joseph France | → $95 | Upgrade | Hold → Buy | Get Alert |
12/08/2022 | Buy Now | 30.65% | Mizuho | Ann Hynes | $80 → $87 | Maintains | Neutral | Get Alert |
12/08/2022 | Buy Now | 32.15% | Stephens & Co. | Scott Fidel | $86 → $88 | Maintains | Equal-Weight | Get Alert |
11/02/2022 | Buy Now | 29.15% | Stephens & Co. | Scott Fidel | $85 → $86 | Maintains | Equal-Weight | Get Alert |
11/02/2022 | Buy Now | 20.14% | Mizuho | Ann Hynes | $78 → $80 | Maintains | Neutral | Get Alert |
08/26/2022 | Buy Now | 54.68% | SVB Leerink | Whit Mayo | $95 → $103 | Maintains | Outperform | Get Alert |
08/01/2022 | Buy Now | 41.16% | RBC Capital | Frank Morgan | $84 → $94 | Maintains | Outperform | Get Alert |
08/01/2022 | Buy Now | 50.17% | Raymond James | John Ransom | $85 → $100 | Maintains | Strong Buy | Get Alert |
07/29/2022 | Buy Now | 17.13% | Mizuho | Ann Hynes | $69 → $78 | Maintains | Neutral | Get Alert |
07/29/2022 | Buy Now | 27.65% | Barclays | Sarah James | $75 → $85 | Maintains | Underweight | Get Alert |
07/28/2022 | Buy Now | 35.16% | UBS | Andrew Mok | $82 → $90 | Maintains | Buy | Get Alert |
06/17/2022 | Buy Now | — | Loop Capital | Joseph France | — | Initiates | → Hold | Get Alert |
05/05/2022 | Buy Now | 42.66% | SVB Leerink | Whit Mayo | $90 → $95 | Maintains | Outperform | Get Alert |
05/05/2022 | Buy Now | 27.65% | Raymond James | John Ransom | $80 → $85 | Maintains | Strong Buy | Get Alert |
04/08/2022 | Buy Now | 35.16% | SVB Leerink | Whit Mayo | $80 → $90 | Maintains | Outperform | Get Alert |
03/02/2022 | Buy Now | 17.13% | Credit Suisse | Nick Giovacchini | $74 → $78 | Maintains | Outperform | Get Alert |
03/01/2022 | Buy Now | 20.14% | SVB Leerink | Whit Mayo | $83 → $80 | Maintains | Outperform | Get Alert |
11/01/2021 | Buy Now | 3.62% | Credit Suisse | — | — | Maintains | Outperform | Get Alert |
09/27/2021 | Buy Now | 27.65% | SVB Leerink | Whit Mayo | — | Initiates | → Outperform | Get Alert |
09/24/2021 | Buy Now | 21.64% | UBS | Andrew Mok | — | Initiates | → Buy | Get Alert |
09/20/2021 | Buy Now | — | Credit Suisse | A.J. Rice | — | Upgrade | Neutral → Outperform | Get Alert |
09/10/2021 | Buy Now | 18.64% | Cowen & Co. | Gary Taylor | — | Initiates | → Outperform | Get Alert |
08/12/2021 | Buy Now | 3.62% | Barclays | Sarah James | — | Initiates | → Underweight | Get Alert |
08/04/2021 | Buy Now | 2.12% | Credit Suisse | — | — | Maintains | Neutral | Get Alert |
The latest price target for Acadia Healthcare Co (NASDAQ:ACHC) was reported by Cantor Fitzgerald on July 10, 2024. The analyst firm set a price target for $90.00 expecting ACHC to rise to within 12 months (a possible 35.16% upside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for Acadia Healthcare Co (NASDAQ:ACHC) was provided by Cantor Fitzgerald, and Acadia Healthcare Co reiterated their neutral rating.
The last upgrade for Acadia Healthcare Co Inc happened on April 25, 2024 when Deutsche Bank raised their price target to $70. Deutsche Bank previously had a sell for Acadia Healthcare Co Inc.
The last downgrade for Acadia Healthcare Co Inc happened on April 20, 2023 when Deutsche Bank changed their price target from $75 to $63 for Acadia Healthcare Co Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acadia Healthcare Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acadia Healthcare Co was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
While ratings are subjective and will change, the latest Acadia Healthcare Co (ACHC) rating was a reiterated with a price target of $90.00 to $90.00. The current price Acadia Healthcare Co (ACHC) is trading at is $66.59, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.